Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novo-Nordisk Graphic](https://lunarcrush.com/gi/w:26/t:$nvo.png) Novo-Nordisk (NVO)

Novo Nordisk is acquiring Akero Therapeutics for $XXX billion to expand its pipeline for liver disease treatments. The company is also restructuring and cutting 9000 jobs globally due to rising competition and lowered profit outlook.

### About Novo-Nordisk
Novo Nordisk (NVO) is a pharmaceutical company specializing in diabetes and obesity treatments.  
Novo-Nordisk uses the ticker $NVO for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$nvo/insights)
- Novo-Nordisk (NVO) social dominance is up XXX% from the previous week.

### Price: $XXXXX [#](/topic/$nvo/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/close.tsv)  
The price action is likely influenced by a combination of factors. The positive clinical trial results and Wegovy's cardiovascular benefits are likely supporting the price, while the lowered sales outlook and increased competition are likely putting downward pressure on the stock.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | -XXXX% |

**1-Year High**: $XXXXXX on 2024-10-17  
**1-Year Low**: $XXXXX on 2025-08-06  
  
  
### AltRank: XXXXX [#](/topic/$nvo/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/alt_rank.tsv)  
Novo-Nordisk (NVO) is currently AltRank #1,374 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +48  
**1 Month**: XXXXX +1,353  
**6 Months**: XXXXX -XX  
**1 Year**: XXXXX +970  
**1-Year High**: XXXXX on 2025-07-17  
**1-Year Low**: X on 2025-06-10  
  
  
### Galaxy Score: XXXXX [#](/topic/$nvo/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -X  
**1 Month**: XX -XX  
**6 Months**: XX +28  
**1 Year**: XX +2  
**1-Year High**: XX on 2025-06-10  
**1-Year Low**: XX on 2025-01-03  
  
  
### Engagements: XXXXXXX [#](/topic/$nvo/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXXXX -XX%  
**1 Month**: XXXXXXXXXX +46%  
**6 Months**: XXXXXXXXXXX +195%  
**1 Year**: XXXXXXXXXXX +249%  
**1-Year High**: XXXXXXXXX on 2025-06-23  
**1-Year Low**: XXXXXX on 2024-10-18  

| Social Network | X       | TikTok | YouTube | Reddit |
| -------------- | -       | ------ | ------- | ------ |
| Engagements    | XXXXXXX | XXXXXX | XXXXXX  | XXX    |
  

  
  
### Mentions: XXXXX [#](/topic/$nvo/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/posts_active.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXX  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +86%  
**1 Year**: XXXXXX +100%  
**1-Year High**: XXXXX on 2025-06-25  
**1-Year Low**: XXX on 2024-10-18  

| Social Network | X     | TikTok | YouTube | Reddit |
| -------------- | -     | ------ | ------- | ------ |
| Mentions       | XXXXX | XXX    | XX      | X      |
  

  
  
### Creators: XXX [#](/topic/$nvo/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +85%  
**1 Year**: XXXXXX +129%  
**1-Year High**: XXXXX on 2025-06-25  
**1-Year Low**: XXX on 2024-10-18  

The most influential creators that mention Novo-Nordisk in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@TheLongInvest](/creator/twitter/TheLongInvest)     | X    | XXXXXXX   | X     | XXXXXXX     |
| [@novonordisk](/creator/tiktok/novonordisk)          | X    | XXXXXX    | XX    | XXXXXX      |
| [@Mindset4Money_X](/creator/twitter/Mindset4Money_X) | X    | XXXXXX    | X     | XXXXXX      |
| [@TheRayMyers](/creator/twitter/TheRayMyers)         | X    | XXXXXX    | XX    | XXXXXX      |
| [@ValueSense_io](/creator/twitter/ValueSense_io)     | X    | XXXXXX    | XX    | XXXXXX      |
| [@investseekers](/creator/twitter/investseekers)     | X    | XXXXX     | XX    | XXXXX       |
| [@TacticzH](/creator/twitter/TacticzH)               | X    | XXXXXX    | XX    | XXXXX       |
| [@ChartWaveTrade](/creator/twitter/ChartWaveTrade)   | X    | XXXXX     | X     | XXXXX       |
| [@NighthawkTradez](/creator/twitter/NighthawkTradez) | X    | XXXXX     | X     | XXXXX       |
| [@ResearchPulse1](/creator/twitter/ResearchPulse1)   | XX   | XXXXX     | XX    | XXXXX       |

[View More](/list/creators/$nvo/100)
  
  
### Sentiment: XX% [#](/topic/$nvo/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +4%  
**6 Months**: XX% +1%  
**1 Year**: XX% +7%  
**1-Year High**: XX% on 2024-11-03  
**1-Year Low**: XX% on 2025-05-31  

**Most Supportive Themes**
- **Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits:** (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- **Long-Term Growth Potential and Valuation:** (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- **Expert Analysis and Recommendations:** (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
  
**Most Critical Themes**
- **Competition and Market Share Concerns:** (20%)  Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- **Negative Guidance and Restructuring:** (5%)  Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXXXX  | XX% | XXXXXXX | XX% | XXXXXXX  | XX% |
| TikTok  | XXX      | X%  | XXXXXX  | XX% | XXXXXX   | X%  |
| YouTube | XXX      | X%  | XXXXXX  | X%  | XX       | X%  |
| Reddit  | XXX      | X%  | XXX     | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXXX  | XX% | XXXXXXX | XX% | XXXXXXX  | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$nvo/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.242%  
**1 Month**: XXXXX% +0.039%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% +0.0068%  
**1-Year High**: XXXXX% on 2025-06-25  
**1-Year Low**: XXXXX% on 2025-07-26  
  
  
### Market Dominance: XXXXX% [#](/topic/$nvo/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2025-08-06  
  
  
### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/$nvo/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$nvo/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$nvo/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXXX -$4.60%  
**1 Month**: $XXXXXXXXXXXXXXX -$1.90%  
**6 Months**: $XXXXXXXXXXXXXXX -$3.30%  
**1 Year**: $XXXXXXXXXXXXXXX -$53%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2024-10-17  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2025-08-06  

**Top assets mentioned**
In the posts about Novo-Nordisk in the last XX hours

[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[UnitedHealth Group (UNH)](/topic/$unh)
[Hims & Hers Health, Inc. (HIMS)](/topic/hims-hers)
[Akropolis (AKRO)](/topic/$akro)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Advanced Micro Devices (AMD)](/topic/advanced-micro-devices)
[Akero Therapeutics, Inc. Common Stock (AKRO)](/topic/akro-akero-therapeutics-inc)
[Hims & Hers Health, Inc. (HIMS)](/topic/$hims)

**Top topics mentioned**
In the posts about Novo-Nordisk in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [$novcde](/topic/$novcde), [eli lilly](/topic/eli-lilly), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [investment](/topic/investment), [stocks](/topic/stocks), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks financial services](/topic/stocks-financial-services), [novo](/topic/novo), [$lly](/topic/$lly), [$unh](/topic/$unh), [hims hers](/topic/hims-hers), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks communication services](/topic/stocks-communication-services), [$akro](/topic/$akro), [$pfe](/topic/$pfe), [advanced micro devices](/topic/advanced-micro-devices), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [acquisition](/topic/acquisition), [$hims](/topic/$hims), [$vktx](/topic/$vktx), [weight loss](/topic/weight-loss), [$mrk](/topic/$mrk), [$omer](/topic/$omer), [coins layer 1](/topic/coins-layer-1), [$oscr](/topic/$oscr), [tesla](/topic/tesla), [momentum](/topic/momentum), [$pypl](/topic/$pypl), [$21b](/topic/$21b), [stocks industrials](/topic/stocks-industrials), [$amzn](/topic/$amzn), [money](/topic/money), [costco](/topic/costco), [$dlo](/topic/$dlo), [johnson johnson](/topic/johnson-johnson), [$orcl](/topic/$orcl), [chapter 11](/topic/chapter-11), [stockmarket](/topic/stockmarket), [$mdgl](/topic/$mdgl), [$dave](/topic/$dave), [cuts](/topic/cuts), [$nbis](/topic/$nbis), [targets](/topic/targets), [$nvda](/topic/$nvda), [$cost](/topic/$cost), [$qcom](/topic/$qcom), [$azn](/topic/$azn), [$root](/topic/$root), [stocks banks](/topic/stocks-banks), [longterm](/topic/longterm), [about to](/topic/about-to), [jan](/topic/jan), [taiwan semiconductor](/topic/taiwan-semiconductor), [catalent inc](/topic/catalent-inc), [donald trump](/topic/donald-trump), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$jnj](/topic/$jnj), [adobe inc](/topic/adobe-inc), [$amd](/topic/$amd), [$uber](/topic/$uber), [$ionq](/topic/$ionq), [employees](/topic/employees), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$52b](/topic/$52b), [$googl](/topic/$googl), [$hsbc](/topic/$hsbc), [$aapl](/topic/$aapl), [$mtsr](/topic/$mtsr), [$meli](/topic/$meli), [denmark](/topic/denmark), [$ctlt](/topic/$ctlt), [$abbv](/topic/$abbv), [$asml](/topic/$asml), [upside](/topic/upside), [india](/topic/india), [has been](/topic/has-been), [$srrk](/topic/$srrk), [$cnc](/topic/$cnc), [$cprt](/topic/$cprt), [$oklo](/topic/$oklo), [$lulu](/topic/$lulu), [$asts](/topic/$asts), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [coins meme](/topic/coins-meme), [$bmy](/topic/$bmy), [over the](/topic/over-the), [danish krone](/topic/danish-krone), [$tmdx](/topic/$tmdx), [$amgn](/topic/$amgn), [$340m](/topic/$340m), [$nflx](/topic/$nflx), [$hood](/topic/$hood), [tariffs](/topic/tariffs), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$spy](/topic/$spy), [$ma](/topic/$ma), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$elv](/topic/$elv)

### Top Social Posts [#](/topic/$nvo/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"There is ongoing negotiations with $LLy and very likely $NVO. Lilly preempted by X new factories but White House was unhappy and wanted to be in the announcement. Lilly now relies on cash pay long term thats growing the fastest . I doubt will make big concession that will harm Lilly direct. Novo will likely announce more factories as @ResearchPulse1 suggested and likely reduce Sema price in USA. I believe outcome will be good for more coverage likely Medicare as Dr Oz has an insight of massive class benefit and health cost reduction. I doubt they would announce attack on compounders but there"  
[X Link](https://x.com/bioinvestor24/status/1978941478513660140) [@bioinvestor24](/creator/x/bioinvestor24) 2025-10-16T21:49Z 4387 followers, 6977 engagements


"$NVO $LLY they probably will be selling glp1s for $200-300 a month in a few yrs. They will have to sell 4-5x the amount to make the same money. Thats never going to happen selling 5x more glp1s in a few yrs"  
[X Link](https://x.com/Martinperiu6/status/1978940962916229214) [@Martinperiu6](/creator/x/Martinperiu6) 2025-10-16T21:47Z 1432 followers, XXX engagements


"I wonder if $LLY & $NVO are dropping after hours cuz of @ferrisbuhler81 podcast the other day with Joe Rogan. He specifically called out both of these companies on several occasions"  
[X Link](https://x.com/TimproviseDIY/status/1978940821333328266) [@TimproviseDIY](/creator/x/TimproviseDIY) 2025-10-16T21:47Z XXX followers, XXX engagements


"💥 STRONG SECTOR ROTATION IN PLAY $ELBM $ENVX $EOSE $FFAI $GLXY $JD $NVO $NVTS $ORIS $WULF Momentum cycle shiftingfresh setups forming this session. 🔗"  
[X Link](https://x.com/pfmym34753846/status/1978939821650514306) [@pfmym34753846](/creator/x/pfmym34753846) 2025-10-16T21:43Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Novo-Nordisk Graphic Novo-Nordisk (NVO)

Novo Nordisk is acquiring Akero Therapeutics for $XXX billion to expand its pipeline for liver disease treatments. The company is also restructuring and cutting 9000 jobs globally due to rising competition and lowered profit outlook.

About Novo-Nordisk

Novo Nordisk (NVO) is a pharmaceutical company specializing in diabetes and obesity treatments.
Novo-Nordisk uses the ticker $NVO for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • Novo-Nordisk (NVO) social dominance is up XXX% from the previous week.

Price: $XXXXX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by a combination of factors. The positive clinical trial results and Wegovy's cardiovascular benefits are likely supporting the price, while the lowered sales outlook and increased competition are likely putting downward pressure on the stock.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% -XXXX%

1-Year High: $XXXXXX on 2024-10-17
1-Year Low: $XXXXX on 2025-08-06

AltRank: XXXXX #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novo-Nordisk (NVO) is currently AltRank #1,374 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX +48
1 Month: XXXXX +1,353
6 Months: XXXXX -XX
1 Year: XXXXX +970
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-06-10

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX -XX
6 Months: XX +28
1 Year: XX +2
1-Year High: XX on 2025-06-10
1-Year Low: XX on 2025-01-03

Engagements: XXXXXXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX -XX%
1 Month: XXXXXXXXXX +46%
6 Months: XXXXXXXXXXX +195%
1 Year: XXXXXXXXXXX +249%
1-Year High: XXXXXXXXX on 2025-06-23
1-Year Low: XXXXXX on 2024-10-18

Social Network X TikTok YouTube Reddit
Engagements XXXXXXX XXXXXX XXXXXX XXX

Mentions: XXXXX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXX -XX%
6 Months: XXXXXX +86%
1 Year: XXXXXX +100%
1-Year High: XXXXX on 2025-06-25
1-Year Low: XXX on 2024-10-18

Social Network X TikTok YouTube Reddit
Mentions XXXXX XXX XX X

Creators: XXX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
1 Month: XXXXX -XX%
6 Months: XXXXXX +85%
1 Year: XXXXXX +129%
1-Year High: XXXXX on 2025-06-25
1-Year Low: XXX on 2024-10-18

The most influential creators that mention Novo-Nordisk in the last XX hours

Creator Rank Followers Posts Engagements
@TheLongInvest X XXXXXXX X XXXXXXX
@novonordisk X XXXXXX XX XXXXXX
@Mindset4Money_X X XXXXXX X XXXXXX
@TheRayMyers X XXXXXX XX XXXXXX
@ValueSense_io X XXXXXX XX XXXXXX
@investseekers X XXXXX XX XXXXX
@TacticzH X XXXXXX XX XXXXX
@ChartWaveTrade X XXXXX X XXXXX
@NighthawkTradez X XXXXX X XXXXX
@ResearchPulse1 XX XXXXX XX XXXXX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +4%
6 Months: XX% +1%
1 Year: XX% +7%
1-Year High: XX% on 2024-11-03
1-Year Low: XX% on 2025-05-31

Most Supportive Themes

  • Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
  • Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
  • Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.

Most Critical Themes

  • Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
  • Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXXX XX% XXXXXXX XX% XXXXXXX XX%
TikTok XXX X% XXXXXX XX% XXXXXX X%
YouTube XXX X% XXXXXX X% XX X%
Reddit XXX X% XXX X% X X%
Total XXXXXXX XX% XXXXXXX XX% XXXXXXX XX%

Social Dominance: XXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.242%
1 Month: XXXXX% +0.039%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% +0.0068%
1-Year High: XXXXX% on 2025-06-25
1-Year Low: XXXXX% on 2025-07-26

Market Dominance: XXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-08-06

Market Cap: $XXXXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX -$4.60%
1 Month: $XXXXXXXXXXXXXXX -$1.90%
6 Months: $XXXXXXXXXXXXXXX -$3.30%
1 Year: $XXXXXXXXXXXXXXX -$53%
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-17
1-Year Low: $XXXXXXXXXXXXXXX on 2025-08-06

Top assets mentioned In the posts about Novo-Nordisk in the last XX hours

Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) UnitedHealth Group (UNH) Hims & Hers Health, Inc. (HIMS) Akropolis (AKRO) Pfizer, Inc. (PFE) Advanced Micro Devices (AMD) Akero Therapeutics, Inc. Common Stock (AKRO) Hims & Hers Health, Inc. (HIMS)

Top topics mentioned In the posts about Novo-Nordisk in the last XX hours

stocks healthcare, stocks technology, $novcde, eli lilly, stocks consumer cyclical, investment, stocks, stocks consumer defensive, stocks financial services, novo, $lly, $unh, hims hers, stocks bitcoin treasuries, stocks communication services, $akro, $pfe, advanced micro devices, akro akero therapeutics inc, acquisition, $hims, $vktx, weight loss, $mrk, $omer, coins layer 1, $oscr, tesla, momentum, $pypl, $21b, stocks industrials, $amzn, money, costco, $dlo, johnson johnson, $orcl, chapter 11, stockmarket, $mdgl, $dave, cuts, $nbis, targets, $nvda, $cost, $qcom, $azn, $root, stocks banks, longterm, about to, jan, taiwan semiconductor, catalent inc, donald trump, coins solana ecosystem, $jnj, adobe inc, $amd, $uber, $ionq, employees, stocks bitcoin miners, $52b, $googl, $hsbc, $aapl, $mtsr, $meli, denmark, $ctlt, $abbv, $asml, upside, india, has been, $srrk, $cnc, $cprt, $oklo, $lulu, $asts, regeneron pharmaceuticals inc, coins meme, $bmy, over the, danish krone, $tmdx, $amgn, $340m, $nflx, $hood, tariffs, stocks crypto treasuries, $spy, $ma, sarepta therapeutics inc, $elv

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"There is ongoing negotiations with $LLy and very likely $NVO. Lilly preempted by X new factories but White House was unhappy and wanted to be in the announcement. Lilly now relies on cash pay long term thats growing the fastest . I doubt will make big concession that will harm Lilly direct. Novo will likely announce more factories as @ResearchPulse1 suggested and likely reduce Sema price in USA. I believe outcome will be good for more coverage likely Medicare as Dr Oz has an insight of massive class benefit and health cost reduction. I doubt they would announce attack on compounders but there"
X Link @bioinvestor24 2025-10-16T21:49Z 4387 followers, 6977 engagements

"$NVO $LLY they probably will be selling glp1s for $200-300 a month in a few yrs. They will have to sell 4-5x the amount to make the same money. Thats never going to happen selling 5x more glp1s in a few yrs"
X Link @Martinperiu6 2025-10-16T21:47Z 1432 followers, XXX engagements

"I wonder if $LLY & $NVO are dropping after hours cuz of @ferrisbuhler81 podcast the other day with Joe Rogan. He specifically called out both of these companies on several occasions"
X Link @TimproviseDIY 2025-10-16T21:47Z XXX followers, XXX engagements

"💥 STRONG SECTOR ROTATION IN PLAY $ELBM $ENVX $EOSE $FFAI $GLXY $JD $NVO $NVTS $ORIS $WULF Momentum cycle shiftingfresh setups forming this session. 🔗"
X Link @pfmym34753846 2025-10-16T21:43Z XXX followers, XXX engagements

Novo-Nordisk (NVO)
/topic/$nvo